LRATD2 and central nervous system cancer: Combined with our research, it is speculated that inhibiting the expression of FAM84B can affect the AKT/GSK-3β/β-catenin pathway to regulate the key proteins of the cell cycle, induce cell cycle arrest, and then inhibit the malignant proliferation of glioma cells.